KYMERA THERAPEUTICS ($KYMR) is expected to release its quarterly earnings data on Friday, May 9th before market open, per Finnhub. Analysts are expecting revenue of $10,357,845 and earnings of -$0.94 per share.
You can see Quiver Quantitative's $KYMR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KYMERA THERAPEUTICS Insider Trading Activity
KYMERA THERAPEUTICS insiders have traded $KYMR stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $KYMR stock by insiders over the last 6 months:
- BRUCE N. JACOBS (Chief Financial Officer) has made 0 purchases and 2 sales selling 7,035 shares for an estimated $214,219.
- ELLEN CHINIARA (Chief Legal Officer) has made 0 purchases and 3 sales selling 5,370 shares for an estimated $198,884.
- JARED GOLLOB (Chief Medical Officer) has made 0 purchases and 2 sales selling 5,740 shares for an estimated $174,785.
- PAMELA ESPOSITO sold 2,500 shares for an estimated $122,500
- JEREMY G CHADWICK (Chief Operating Officer) has made 0 purchases and 2 sales selling 1,383 shares for an estimated $42,113.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KYMERA THERAPEUTICS Hedge Fund Activity
We have seen 87 institutional investors add shares of KYMERA THERAPEUTICS stock to their portfolio, and 91 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 688,967 shares (+14.9%) to their portfolio in Q4 2024, for an estimated $27,717,142
- AVORO CAPITAL ADVISORS LLC added 650,000 shares (+14.4%) to their portfolio in Q4 2024, for an estimated $26,149,499
- DEEP TRACK CAPITAL, LP removed 600,326 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $24,151,114
- DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) added 593,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $23,856,390
- JANUS HENDERSON GROUP PLC added 362,276 shares (+2397.9%) to their portfolio in Q4 2024, for an estimated $14,574,363
- ECOR1 CAPITAL, LLC added 350,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $14,080,499
- REDMILE GROUP, LLC removed 292,824 shares (-21.0%) from their portfolio in Q4 2024, for an estimated $11,780,309
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KYMERA THERAPEUTICS Price Targets
Multiple analysts have issued price targets for $KYMR recently. We have seen 2 analysts offer price targets for $KYMR in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Etzer Darout from BMO Capital set a target price of $55.0 on 12/05/2024
- Derek Archila from Wells Fargo set a target price of $57.0 on 12/02/2024
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
